1-19 of 19
Lawrence Panasci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P2-01-06: Real-world outcome and cost analysis of the addition of pertuzumab to neoadjuvant therapy in localized HER2 positive breast cancer: a single center experience

Francois Panet, Matt Young, Stephanie Wong, Alice Dragomir, April A. N. Rose, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-01-06.
https://doi.org/10.1158/1538-7445.SABCS22-P2-01-06
Published: 01 March 2023
View articletitled, Abstract P2-01-06: Real-world outcome and cost analysis of the addition of pertuzumab to neoadjuvant therapy in localized HER2 positive breast cancer: a single center experience
Journal Articles

Abstract 300: A new combination therapy to treat metastatic breast cancer

Bahram Sharif-Askari, Raquel Aloyz, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 300.
https://doi.org/10.1158/1538-7445.AM2019-300
Published: 01 July 2019
View articletitled, Abstract 300: A new combination therapy to treat metastatic breast cancer
Journal Articles

Abstract CT131: A randomized (RCT) phase II study of oncolytic reovirus (pelareorep ) plus standard weekly paclitaxel (P) as therapy for metastatic breast cancer (mBC)

Vanessa Bernstein, Susan Ellard, Susan F. Dent, Karen A. Gelmon, Sukhbinder K. Dhesy-Thind, Mihaela Mates, Muhammed Salim, Lawrence Panasci, Xinni Song, Mark Clemons, Dongsheng Tu, Linda J. Hagerman, Lesley Seymour
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT131.
https://doi.org/10.1158/1538-7445.AM2017-CT131
Published: 01 July 2017
View articletitled, Abstract CT131: A randomized (RCT) phase II study of oncolytic reovirus (pelareorep ) plus standard weekly paclitaxel (P) as therapy for metastatic breast cancer (mBC)
Journal Articles

Abstract 268: PARP3 inhibitors in cancer therapy

Bahram Sharif-Askari, David Davidson, Lilian Amrein, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 268.
https://doi.org/10.1158/1538-7445.AM2016-268
Published: 15 July 2016
View articletitled, Abstract 268: PARP3 inhibitors in cancer therapy
Journal Articles

Abstract 5327: Simultaneous inhibition of ATR and PARP greatly sensitizes colon cancer cell lines to irinotecan

David Davidson, Atlal Abu-Sanad, Yunzhe Wang, Fatemeh Hasheminasab, Justin Panasci, Raquel Aloyz, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5327.
https://doi.org/10.1158/1538-7445.AM2015-5327
Published: 01 August 2015
View articletitled, Abstract 5327: Simultaneous inhibition of ATR and PARP greatly sensitizes colon cancer cell lines to irinotecan
Journal Articles

Abstract 1881: New therapeutic options for CLL treatment: Src/c-abl-directed molecular re-engineering of chlorambucil and bendamustine

Lilian Amrein, Anne-Laure Larocque, David Davidson, Lisa Peyrard, Daniel Borrelli, Bertrand Jean-Claude, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1881.
https://doi.org/10.1158/1538-7445.AM2014-1881
Published: 01 October 2014
View articletitled, Abstract 1881: New therapeutic options for CLL treatment: Src/c-abl-directed molecular re-engineering of chlorambucil and bendamustine
Journal Articles

Abstract 932: Predictive markers of the in vitro anticancer effect of the pan class I PI3K inhibitor BKM120 in primary B-CLL lymphocytes.

Lilian Amrein, May Shawi, Jeremy Grenier, Raquel Aloys, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 932.
https://doi.org/10.1158/1538-7445.AM2013-932
Published: 15 April 2013
View articletitled, Abstract 932: Predictive markers of the in vitro anticancer effect of the pan class I PI3K inhibitor BKM120 in primary B-CLL lymphocytes.
Journal Articles

Abstract 4692: ABT-888 synergizes treatment of colon cancer cell lines with irinotecan

David Davidson, Yunzhe Wang, Raquel Aloyz, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4692.
https://doi.org/10.1158/1538-7445.AM2012-4692
Published: 15 April 2012
View articletitled, Abstract 4692: ABT-888 synergizes treatment of colon cancer cell lines with irinotecan
Journal Articles

Abstract 5534: Building the organization framework for biopsy-driven translational research: The Quebec Clinical Research Organization in Cancer (Q-CROC) experience

Thérèse Gagnon-Kugler, Zuanel Diaz, Caroline Rousseau, Adriana Aguilar-Mahecha, Thierry Alcindor, Raquel Aloyz, Sarit Assouline, Mark Basik, Dimcho Bachvarov, Luc Bélanger, Naciba Benlimame, Errol Camlioglu, Benoit Chabot, Rosa Christodoulopoulos, André Constantin, Chantal Courtemanche, Isabel Dao, Lise Gosselin, Chantal Guillemette, Marie-Christine Hains, Tina Haliotis, Torsten Holm Nielsen, Marie-Claude Joncas, Petr Kavan, Roscoe Klinck, Michel Lebel, Bernard Lespérance, Koren Mann, Jean-Yves Masson, Peter Metrakos, Suzan McNamara, Wilson H. Miller, Michèle Orain, Lawrence Panasci, Eric Paquet, Michel Philie, Samie Qureshi, Denis Rodrigue, Ayat Salman, Martin Simard, Alan Spatz, Bernard Têtu, Axel Tosikyan, Maria Tsatoumas, Te Vuong, Gerald Batist
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5534.
https://doi.org/10.1158/1538-7445.AM2012-5534
Published: 15 April 2012
View articletitled, Abstract 5534: Building the organization framework for biopsy-driven translational research: The Quebec Clinical Research Organization in Cancer (Q-CROC) experience
Journal Articles

Abstract LB-100: Optimal modulation of DNA repair in CLL therapy

Lilian Amrein, David Davidson, May Shawi, Luca Petruccelli, Wilson Miller, Raquel Aloyz, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): LB-100.
https://doi.org/10.1158/1538-7445.AM10-LB-100
Published: 15 April 2010
View articletitled, Abstract LB-100: Optimal modulation of DNA repair in CLL therapy
Journal Articles

Abstract #1288: Evaluation of the effect of a new combi-molecule targeting the DNA and c-abl vis a vis chlorambucil plus imatinib in primary chronic lymphocytic leukemia in vitro

Lilian Amrein, Zakaria Rachid, Bertrand Jean-Claude, Raquel Aloys, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1288.
Published: 01 May 2009
View articletitled, Abstract #1288: Evaluation of the effect of a new combi-molecule targeting the DNA and c-abl vis a vis chlorambucil plus imatinib in primary chronic lymphocytic leukemia in vitro
Journal Articles

Nilotinib has greater efficacy than imatinib in sensitization of B-CLL lymphocytes to chlorambucil

Lilian Amrein, Anne-Christine Goulet, Raquel Aloyz, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1851.
Published: 01 May 2008
View articletitled, Nilotinib has greater efficacy than imatinib in sensitization of B-CLL lymphocytes to chlorambucil
Journal Articles

Dasatinib sensitizes chronic lymphocytic leukemia lymphocytes to chemotherapeutic agents

Anne-Christine Goulet, Lilian Amrein, Michael Dunn, Raquel Aloyz, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4753.
Published: 01 May 2007
View articletitled, Dasatinib sensitizes chronic lymphocytic leukemia lymphocytes to chemotherapeutic agents
Journal Articles

Xenografts of human hepatocellular carcinoma: A useful model for testing drugs.

Hung T. Huynh, Khee Chee Soo, Pierce Chow, Lawrence Panasci, Evelyne Tran
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1199.
Published: 15 April 2006
View articletitled, Xenografts of human hepatocellular carcinoma: A useful model for testing drugs.
Journal Articles

Xenografts of human hepatocellular carcinoma: A tool for screening drugs used in treatment of this disease

Thanh Hung Nguyen, Phuc Tien Do, Khee Chee Soo, Pierce Chow, Lawrence Panasci, Hung Huynh
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 464–465.
Published: 01 May 2005
View articletitled, Xenografts of human hepatocellular carcinoma: A tool for screening drugs used in treatment of this disease
Journal Articles

Regulation of Cisplatin Resistance and Homologous Recombinational Repair by the TFIIH Subunit XPD

Raquel Aloyz, Zhi-Yuan Xu, Vanessa Bello, Josée Bergeron, Fei-Yu Han, Yifei Yan, Areti Malapetsa, Moulay A. Alaoui-Jamali, Alessandra M. V. Duncan, Lawrence Panasci
Journal: Cancer Research
Cancer Res (2002) 62 (19): 5457–5462.
Published: 01 October 2002
View articletitled, Regulation of Cisplatin Resistance and Homologous Recombinational Repair by the TFIIH Subunit XPD
Open the PDF for Regulation of Cisplatin Resistance and Homologous Recombinational Repair by the TFIIH Subunit XPD in another window
Journal Articles

Potentiation of Chlorambucil Cytotoxicity in B-Cell Chronic Lymphocytic Leukemia by Inhibition of DNA-dependent Protein Kinase Activity Using Wortmannin

Garyfallia Christodoulopoulos, Catherine Muller, Bernard Salles, Rehan Kazmi, Lawrence Panasci
Journal: Cancer Research
Cancer Res (1998) 58 (9): 1789–1792.
Published: 01 May 1998
View articletitled, Potentiation of Chlorambucil Cytotoxicity in B-Cell Chronic Lymphocytic Leukemia by Inhibition of DNA-dependent Protein Kinase Activity Using Wortmannin
Open the PDF for Potentiation of Chlorambucil Cytotoxicity in B-Cell Chronic Lymphocytic Leukemia by Inhibition of DNA-dependent Protein Kinase Activity Using Wortmannin in another window
Journal Articles

Correspondence re: M. D. Dabholkar et al., Malignant and Nonmalignant Brain Tissues Differ in Their Messenger RNA Expression Patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261–1266, 1995

Lawrence Panasci, Angela McQuillan, Areti Malapetsa
Journal: Cancer Research
Cancer Res (1995) 55 (17): 3933.
Published: 01 September 1995
View articletitled, Correspondence re: M. D. Dabholkar et al., Malignant and Nonmalignant Brain Tissues Differ in Their Messenger RNA Expression Patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261–1266, 1995
Open the PDF for Correspondence re: M. D. Dabholkar et al., Malignant and Nonmalignant Brain Tissues Differ in Their Messenger RNA Expression Patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261–1266, 1995 in another window
Journal Articles

Transport, Metabolism, and DNA Interaction of Melphalan in Lymphocytes from Patients with Chronic Lymphocytic Leukemia

Lawrence Panasci, Derin Henderson, San Juana Torres-Garcia, Violetta Skalski, Stephen Caplan, Maureen Hutchinson
Journal: Cancer Research
Cancer Res (1988) 48 (7): 1972–1976.
Published: 01 April 1988
View articletitled, Transport, Metabolism, and DNA Interaction of Melphalan in Lymphocytes from Patients with Chronic Lymphocytic Leukemia
Open the PDF for Transport, Metabolism, and DNA Interaction of Melphalan in Lymphocytes from Patients with Chronic Lymphocytic Leukemia in another window